A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci

Thyroid

Volumn 15, Issue 12, 2005, Pages 1349-1354

  Tsilchorozidou, Tasoula ^a   Vafiadou, Eleni ^a   Yovos, John G ^a   Romeo, Giovani ^b,c   McKay, James ^b   Lesueur, Fabienne ^b   Bonora, Elena ^c  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CANCER SIZE; CHROMOSOME 2Q; CLINICAL ARTICLE; FAMILIAL CANCER; FEMALE; FPTC GENE; GENE; GENE LOCUS; GENE MAPPING; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GREECE; HASHIMOTO DISEASE; HUMAN; LINKAGE ANALYSIS; MALE; MICROSATELLITE MARKER; MNG1 GENE; MULTINODULAR GOITER; NMTC1 GENE; NODULAR GOITER; PEDIGREE ANALYSIS; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; PRN GENE; SEX RATIO; TCO GENE; THYROID ADENOMA; THYROID PAPILLARY CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; CARCINOMA, PAPILLARY; CHROMOSOME MAPPING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); LOD SCORE; MALE; MIDDLE AGED; PEDIGREE; THYROID NEOPLASMS;

EID: 31144449987     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2005.15.1349     Document Type: Article

References (40)

1. Eng C 2000 Familial papillary thyroid cancer - Many syndromes, too many genes? J Clin Endocrinol Metab 85:1755-1757.
2. Fagin JA 1997 Familial nonmedullary thyroid carcinoma - The case for genetic susceptibility. J Clin Endocrinol Metab 82:342-344.
3. Lupoli G, Vitale G, Caraglia M, Fittipaldi MR, Abbruzzese A, Tagliaferri P, Bianco AR 1999 Familial papillary thyroid microcarcinoma: A new clinical entity. Lancet 353:637-639.
4. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306.
5. Stoffer SS, Van Dyke DL, Bach JV, Szpunar W, Weiss L 1986 Familial papillary carcinoma of the thyroid. Am J Med Genet 25:775-782.
6. Hrafnkelsson J, Tulinius H, Jonasson JG, Olafsdottir G, Sigvaldason H 1989 Papillary thyroid carcinoma in Iceland. A study of the occurrence in families and the coexistence of other primary tumours. Acta Oncol 28:785-788.
7. Hramkelsson J, Tulinius H, Jonasson JG, Sigvaldason H 2001 Familial non-medullary thyroid cancer in Iceland. J Med Genet 38:189-191.
8. Kwok CG, McDougall IR 1995 Familial differentiated carcinoma of the thyroid: Report of five pairs of siblings. Thyroid 5:395-397.
9. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D 1998 A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63:1743-1748.
10. Bignell GR, Canzian F, Shayeghi M, Stark M, Shugart YY, Biggs P, Mangion J, Hamoudi R, Rosenblatt J, Buu P, Sun S, Stoffer SS, Goldgar DE, Romeo G, Houlston RS, Narod SA, Stratton MR, Foulkes WD 1997 Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61:1123-1130.
11. Malchoff CD, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Joshi V, Arnold A, Malchoff DM 2000 Papillary thyroid carcinoma associated with papillary renal neoplasia: Genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 85:1758-1764.
12. Lesueur F, Corbex M, McKay JD, Lima J, Scares P, Griseri P, Burgess J, Ceccherini I, Landolfi S, Papotti M, Amorim A, Goldgar DE, Romeo G 2002 Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma. J Med Genet 39:260-265.
13. McKay JD, Lesueur F, Jonard L, Pastore A, Williamson J, Hoffman L, Burgess J, Duffield A, Papotti M, Stark M, Sobol H, Maes B, Murat A, Kaariainen H, Bertholon-Gregoire M, Zini M, Rossing MA, Toubert ME, Bonichon F, Cavarec M, Bernard AM, Boneu A, Leprat F, Haas O, Lasset C, Schlumberger M, Canzian F, Goldgar DE, Romeo G 2001 Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 69:440-446.
14. Hedinger C, Williams ED, Sabin LH (eds) 1998 Histological Typing of Thyroid Tumors, 2nd ed. World Health Organization. Springer Verlag, Heidelberg.
15. Lathrop GM and Lalouel JM 1984 Easy calculations of iod scores and genetic risks on small computers. Am J Hum Genet 36:460-465.
16. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES 1996 Parametric and nonparametric linkage analysis: A unified multipoint approach. Am J Hum Genet 58:1347-1363.
17. Kong A and Cox NJ 1997 Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 61:1179-1188.
18. Lesueur F, Stark M, Tocco T, Ayadi H, Delisle MJ, Goldgar DE, Schlumberger M, Romeo G, Canzian F 1999 Genetic heterogeneity in familial nonmedullary thyroid carcinoma: Exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab 84:2157-2162.
19. McKay JD, Thompson D, Lesueur F, Stankov K, Pastore A, Watfah C, Strolz S, Riccabona G, Moncayo R, Romeo G, Goldgar DE 2004 Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer. J Med Genet 41:407-412.
20. Koutras DA, Piperingos GD, Mantzos J, Boukis M, Karaiskos KS, Hadjiioanou S 1990 Iodine nutrition and iodine deficiency in Greece: Sighs of improvement. In: Delange F, Dunn JT, Glinoer D (eds) Iodine Deficiency in Europe: A Continuing Concern. Plenum Press, New York, pp, 421-426.
21. Doufas AG, Mastorakos G, Chatziioannou S, Tseleni-Balafouta S, Piperingos G, Boukis MA, Mantzos E, Caraiskos CS, Mantzos J, Alevizaki M, Koutras DA 1999 The predominant form of non-toxic goiter in Greece is now autoimmune thyroiditis. Eur J Endocrinol 140:505-511.
22. Tsatsoulis A, Johnson EO, Andricula M, Kalogera C, Svarna E, Spyroy P, Seferiadis K, Tsolas O 1999 Thyroid autoimmunity is associated with higher urinary iodine concentrations in an iodine-deficient area of Northwestern Greece. Thyroid 9:279-283.
23. Boukis MA, Koutras DA, Souvatzoglou A, Evangelopoulou A, Vrontakis M, Moulopoulos SD 1983 Thyroid hormone and immunological studies in endemic goiter. J Clin Endocrinol Metab 57:859-862.
24. Kahaly GJ, Dienes HP, Beyer J, Hommel G 1998 Iodide induces thyroid autoimmunity in patients with endemic goitre: A randomised, double-blind, placebo-controlled trial. Eur J Endocrinol 139:290-297.
25. Papanastasiou L, Alevizaki M, Piperingos G, Mantzos E, Tseleni-Balafouta S, Koutras DA 2000 The effect of iodine administration on the development of thyroid autoimmunity in patients with nontoxic goiter. Thyroid 10:493-497.
26. Wahner HW, Cuello C, Correa P, Uribe LF, Gaitan E 1966 Thyroid carcinoma in an endemic goiter area, Cali, Colombia. Am J Med 40:58-66.
27. Belfiore A, La Rosa GL, Padova G, Sava L, Ippolito O, Vigneri R 1987 The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer 60:3096-3102.
28. Harach HR, Williams ED 1995 Thyroid cancer and thyroiditis in the goitrous region of Salta, Argentina, before and after iodine prophylaxis. Cln Endocrinol (Oxf) 43: 701-706.
29. Bacher-Stier C, Riccabona G, Totsch M, Kemmler G, Oberaigner W, Moncayo R 1997 Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid 7:733-741.
30. Kazakov VS, Demidchik EP, Astakhova LN 1992 Thyroid cancer after Chernobyl. Nature 359:21.
31. Bounacer A, Wicker R, Caillou B, Cailleux AF, Sarasin A, Schlumberger M, Suarez HG 1997 High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 15:1263-1273.
32. Nikiforov Y, Gnepp DR, Fagin JA 1996 Thyroid lesions in children and adolescents after the Chernobyl disaster: Implications for the study of radiation tumorigenesis. J Clin Endocrinol Metab 81:9-14.
33. Petridou E 1994 Fallout from Chernobyl. Leukaemia in Greece did not rise. BMJ 309:1299; author reply 1300.
34. Sali D, Cardis E, Sztanyik L, Auvinen A, Bairakova A, Dontas N, Grosche B, Kerekes A, Kusic Z, Kusoglu C, Lechpammer S, Lyra M, Michaelis J, Petridou E, Szybinski Z, Tominaga S, Tulbure R, Turnbull A, Valerianova Z 1996 Cancer consequences of the Chernobyl accident in Europe outside the former USSR: A review, Int J Cancer 67:343-352.
35. Ilias I, Alevizaki M, Lakka-Papadodima E, Koutras D 2002 Differentiated thyroid cancer in Greece: 1963-2000. Hormones 1:174-178.
36. Lote K, Andersen K, Nordal E, Brennhovd IO 1980 Familial occurrence of papillary thyroid carcinoma. Cancer 46:1291-1297.
37. Grossman RF, Tu SH, Duh QY, Siperstein AE, Novosolov F, Clark OH 1995 Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 130:892-897; discussion 898-899.
38. Loh KC 1997 Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 7:107-113.
39. Musholt TJ, Musholt PB, Petrich T, Getting G, Knapp WH, Klempnauer J 2000 Familial papillary thyroid carcinoma: Genetics, criteria for diagnosis, clinical features, and surgical treatment. World J Surg 24:1409-1417.
40. Burgess JR, Duffield A, Wilkinson SJ, Ware R, Greenaway TM, Percival J, Huffman L 1997 Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab 82:345-348.